BTTX News and Press, Better Therapeutics Inc. From 11/28/23

2023-11-28 08:49:38 ET More on Better Therapeutics Better Therapeutics, Inc. (BTTX) Q3 2023 Earnings Call Transcript Better Therapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Better Therapeutics Historical...

Savings Expected to Extend Cash Runway Sufficiently to Demonstrate Commercial Traction with AspyreRx in Type 2 Diabetes Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, today disclosed sever...

Better Therapeutics is recognized for its novel cognitive behavioral therapy app, AspyreRx™, leading the way in the North American diabetes digital behavioral therapeutics industry Better Therapeutics, Inc . (NASDAQ: BTTX), a pioneer in developing prescription digital therape...

2023-11-10 08:33:02 ET Better Therapeutics, Inc. (BTTX) Q3 2023 Earnings Conference Call November 09, 2023 08:30 AM ET Company Participants Mark Heinen - Chief Financial Officer Frank Karbe - President and CEO Diane Gomez-Thinnes - Chief Commercial Officer Ma...

Better Therapeutics Inc. (BTTX) is expected to report for Q3 2023

2023-11-09 13:20:12 ET More on Better Therapeutics Better Therapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Better Therapeutics Historical earnings data for Better Therapeutics Financial information for B...

Company obtained FDA authorization for AspyreRx TM to treat adults with type 2 diabetes and announced commercial launch Company to host a conference call and webcast today at 8:30 a.m. ET Better Therapeutics, Inc . (NASDAQ: BTTX), a pioneer in developing prescription dig...

Better Therapeutics, Inc . (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics to treat cardiometabolic diseases, today announced it will release its third quarter 2023 financial results before the market opens on Thursday, November 09, 2023. Management will host a confere...

Company to showcase AspyreRx™ Company to host sponsored education session on Tuesday, October 31, 2023; A novel approach to treating type 2 diabetes Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) to treat car...

2023-10-16 09:56:56 ET DENVER, Colo., Oct. 16, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; LQR House Inc (NASDAQ: LQR), Better Therapeutics Inc (NASDAQ: BTTX), Mereo BioPharma Group PLC (NASDAQ: MREO)...